Control Bionics (ASX:CBL) EV-to-Revenue : 1.64 (As of Jun. 02, 2025)

View and export this data going back to 2020. Start your Free Trial

What is Control Bionics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Control Bionics's enterprise value is A$8.32 Mil. Control Bionics's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was A$5.06 Mil. Therefore, Control Bionics's EV-to-Revenue for today is 1.64.

The historical rank and industry rank for Control Bionics's EV-to-Revenue or its related term are showing as below:

ASX:CBL' s EV-to-Revenue Range Over the Past 10 Years
Min: -1.14 Med: 1.92 Max: 8.51
Current: 1.64

During the past 4 years, the highest EV-to-Revenue of Control Bionics was 8.51. The lowest was -1.14. And the median was 1.92.

ASX:CBL's EV-to-Revenue is ranked better than
70.63% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 3.095 vs ASX:CBL: 1.64

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-02), Control Bionics's stock price is A$0.03. Control Bionics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.02. Therefore, Control Bionics's PS Ratio for today is 1.30.

Control Bionics EV-to-Revenue Historical Data

The historical data trend for Control Bionics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics EV-to-Revenue Chart

Control Bionics Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

EV-to-Revenue

11.64

3.34

1.30

2.02

Control Bionics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial				-	1.30	-	2.02	-

Competitive Comparison of Control Bionics's EV-to-Revenue

For the Medical Devices subindustry, Control Bionics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Control Bionics's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Control Bionics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Control Bionics's EV-to-Revenue falls into.

Save Embed

;

Save Embed

;

Control Bionics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Control Bionics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	8.320	/	5.062
	=	1.64

Control Bionics's current Enterprise Value is A$8.32 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Control Bionics's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was A$5.06 Mil.

Control Bionics (ASX:CBL) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Control Bionics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.03	/	0.023
	=	1.30

Control Bionics's share price for today is A$0.03.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was A$0.02.

Control Bionics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Control Bionics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Control Bionics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121

Website

https://www.controlbionics.com

Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.